Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (91-100 of 178) with videos related to

Pageof 18
Sort By:
Cancer Research Communications|June 18, 2025
An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without LymphocytopeniaMasayuki Nagahashi, Miki Komatsu, Sayaka Urano, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 4, 2014
Aberrant DNA methylation status of DNA repair genes in breast cancer treated with neoadjuvant chemotherapyYoshiyuki Watanabe, Ichiro Maeda, Ritsuko Oikawa, et al.
Cancer Science|June 9, 2015
Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damageTakayo Fukuda, Wenwen Wu, Maiko Okada, et al.
Surgery Today|January 20, 2025
Germline variants detected by multigene panel testing in patients with suspected hereditary breast cancerYusa Togashi, Masayuki Nagahashi, Mina Kashima, et al.
Anticancer Research|May 6, 2020
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating LymphocytesAyako Bun, Yukie Fujimoto, Tomoko Higuchi, et al.
Cancer Letters|October 27, 2004
Prognostic significance of intra-tumoral estradiol level in breast cancer patientsYasuo Miyoshi, Kenji Akazawa, Shunji Kamigaki, et al.
Oncotarget|February 1, 2021
Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I-III breast cancer: Multicenter studyKazuhiro Kitajima, Yasuo Miyoshi, Tetsuro Sekine, et al.
Breast Cancer (Tokyo, Japan)|February 20, 2021
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer SocietyTakahiko Kawate, Atsushi Yoshida, Sadatoshi Sugae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Prediction of docetaxel response in human breast cancer by gene expression profilingKyoko Iwao-Koizumi, Ryo Matoba, Noriko Ueno, et al.
Scientific Reports|February 14, 2019
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansineMichiko Imamura, Takashi Morimoto, Chiyomi Egawa, et al.
Pageof 18

Showing results (91-100 of 178) with videos related to

Sort By:
Pageof 18
Cancer Research Communications|June 18, 2025
An Acrolein-Based Drug Delivery System Enables Tumor-Specific Sphingosine-1-Phosphate Targeting in Breast Cancer without LymphocytopeniaMasayuki Nagahashi, Miki Komatsu, Sayaka Urano, et al.
Genes to Cells : Devoted to Molecular & Cellular Mechanisms|March 4, 2014
Aberrant DNA methylation status of DNA repair genes in breast cancer treated with neoadjuvant chemotherapyYoshiyuki Watanabe, Ichiro Maeda, Ritsuko Oikawa, et al.
Cancer Science|June 9, 2015
Class I histone deacetylase inhibitors inhibit the retention of BRCA1 and 53BP1 at the site of DNA damageTakayo Fukuda, Wenwen Wu, Maiko Okada, et al.
Surgery Today|January 20, 2025
Germline variants detected by multigene panel testing in patients with suspected hereditary breast cancerYusa Togashi, Masayuki Nagahashi, Mina Kashima, et al.
Anticancer Research|May 6, 2020
Prognostic Significance of Neutrophil-to-lymphocyte Ratio in Luminal Breast Cancers With Low Levels of Tumour-infiltrating LymphocytesAyako Bun, Yukie Fujimoto, Tomoko Higuchi, et al.
Cancer Letters|October 27, 2004
Prognostic significance of intra-tumoral estradiol level in breast cancer patientsYasuo Miyoshi, Kenji Akazawa, Shunji Kamigaki, et al.
Oncotarget|February 1, 2021
Harmonized pretreatment quantitative volume-based FDG-PET/CT parameters for prognosis of stage I-III breast cancer: Multicenter studyKazuhiro Kitajima, Yasuo Miyoshi, Tetsuro Sekine, et al.
Breast Cancer (Tokyo, Japan)|February 20, 2021
Recommendations for the management of breast cancer patients during the COVID-19 pandemic from the Japan Breast Cancer SocietyTakahiko Kawate, Atsushi Yoshida, Sadatoshi Sugae, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2005
Prediction of docetaxel response in human breast cancer by gene expression profilingKyoko Iwao-Koizumi, Ryo Matoba, Noriko Ueno, et al.
Scientific Reports|February 14, 2019
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansineMichiko Imamura, Takashi Morimoto, Chiyomi Egawa, et al.
Pageof 18